Lattice Biologics Ltd. (LBLTF)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Dec 3, 2025
Lattice Biologics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | 2014 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '21 Jun 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | Sep '18 Sep 30, 2018 | Sep '17 Sep 30, 2017 | Sep '16 Sep 30, 2016 | 2014 - 2015 |
| 1.56 | 2.46 | 2.19 | 1.16 | 2.74 | 3.78 | Upgrade | |
Revenue Growth (YoY) | -28.88% | 12.60% | 89.48% | -57.84% | -27.49% | -9.80% | Upgrade |
Cost of Revenue | 0.91 | 1.28 | 1.19 | 0.56 | 2.09 | 2.88 | Upgrade |
Gross Profit | 0.65 | 1.18 | 1 | 0.59 | 0.64 | 0.9 | Upgrade |
Selling, General & Admin | 0.92 | 1.14 | 1.35 | 1.72 | 2.72 | 3.79 | Upgrade |
Research & Development | - | - | 0.01 | 0 | 0.22 | 0.07 | Upgrade |
Operating Expenses | 1.26 | 1.52 | 1.58 | 2.08 | 3.46 | 5.73 | Upgrade |
Operating Income | -0.62 | -0.34 | -0.59 | -1.48 | -2.81 | -4.84 | Upgrade |
Interest Expense | -0.83 | -1.04 | -0.54 | -0.47 | -0.47 | -1.04 | Upgrade |
Other Non Operating Income (Expenses) | 0.58 | -0.02 | 0.12 | 0.25 | 0.32 | -0.27 | Upgrade |
EBT Excluding Unusual Items | -0.86 | -1.39 | -1.01 | -1.7 | -2.96 | -6.15 | Upgrade |
Merger & Restructuring Charges | - | - | - | - | -0.14 | - | Upgrade |
Asset Writedown | - | - | - | - | -0.3 | - | Upgrade |
Other Unusual Items | -0.09 | -0.09 | - | 0.47 | 1.88 | -1.7 | Upgrade |
Pretax Income | -0.95 | -1.48 | -1.01 | -1.23 | -1.52 | -7.85 | Upgrade |
Net Income | -0.95 | -1.48 | -1.01 | -1.23 | -1.52 | -7.85 | Upgrade |
Net Income to Common | -0.95 | -1.48 | -1.01 | -1.23 | -1.52 | -7.85 | Upgrade |
Shares Outstanding (Basic) | 127 | 103 | 93 | 93 | 78 | 48 | Upgrade |
Shares Outstanding (Diluted) | 127 | 103 | 93 | 93 | 78 | 48 | Upgrade |
Shares Change (YoY) | 33.86% | 9.76% | 0.00% | 19.82% | 61.99% | 82.81% | Upgrade |
EPS (Basic) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.16 | Upgrade |
EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 | -0.16 | Upgrade |
Free Cash Flow | -0.7 | -0.06 | 0.11 | 0.03 | -0.77 | -2.18 | Upgrade |
Free Cash Flow Per Share | -0.01 | -0.00 | 0.00 | - | -0.01 | -0.04 | Upgrade |
Gross Margin | 41.44% | 47.93% | 45.58% | 51.35% | 23.54% | 23.72% | Upgrade |
Operating Margin | -39.52% | -13.63% | -26.76% | -128.48% | -102.74% | -128.07% | Upgrade |
Profit Margin | -61.08% | -60.16% | -46.23% | -106.58% | -55.66% | -207.84% | Upgrade |
Free Cash Flow Margin | -44.92% | -2.27% | 5.01% | 2.88% | -28.28% | -57.75% | Upgrade |
EBITDA | -0.26 | -0.06 | -0.38 | -1.28 | -2.59 | -4.36 | Upgrade |
EBITDA Margin | -16.99% | -2.44% | -17.43% | -111.06% | -94.58% | -115.42% | Upgrade |
D&A For EBITDA | 0.35 | 0.28 | 0.2 | 0.2 | 0.22 | 0.48 | Upgrade |
EBIT | -0.62 | -0.34 | -0.59 | -1.48 | -2.81 | -4.84 | Upgrade |
EBIT Margin | -39.52% | -13.63% | -26.76% | -128.48% | -102.74% | -128.07% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.